Advertisement
New Zealand markets closed
  • NZX 50

    11,682.39
    -89.42 (-0.76%)
     
  • NZD/USD

    0.6128
    +0.0006 (+0.10%)
     
  • NZD/EUR

    0.5715
    +0.0001 (+0.02%)
     
  • ALL ORDS

    8,030.30
    +18.20 (+0.23%)
     
  • ASX 200

    7,787.90
    +18.50 (+0.24%)
     
  • OIL

    82.34
    +0.17 (+0.21%)
     
  • GOLD

    2,378.70
    +9.70 (+0.41%)
     
  • NASDAQ

    19,752.30
    -156.56 (-0.79%)
     
  • FTSE

    8,272.46
    +67.35 (+0.82%)
     
  • Dow Jones

    39,134.76
    +299.90 (+0.77%)
     
  • DAX

    18,254.18
    +186.27 (+1.03%)
     
  • Hang Seng

    18,062.97
    -272.35 (-1.49%)
     
  • NIKKEI 225

    38,615.33
    -17.69 (-0.05%)
     
  • NZD/JPY

    97.3860
    +0.1660 (+0.17%)
     

Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test

Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test

Sarepta stock jumped Thursday after Pfizer's rival gene therapy for Duchenne muscular dystrophy failed in final-phase testing.